Theoretical Basis, Laboratory Evidence, and Clinical Research of Chemical Surgery of the Cornea: Cross-Linking by Paz, Amanda C. da et al.
Review Article
Theoretical Basis, Laboratory Evidence, and Clinical Research of
Chemical Surgery of the Cornea: Cross-Linking
Amanda C. da Paz,1 Patrícia A. Bersanetti,1,2 Marcella Q. Salomão,3
Renato Ambrósio Jr.,1,3 and Paulo Schor1
1 Department of Ophthalmology and Visual Sciences, Paulista School of Medicine, Federal University of Sa˜o Paulo (UNIFESP),
Sa˜o Paulo, SP, Brazil
2 Department of Health Informatics, Paulista School of Medicine, Federal University of Sa˜o Paulo (UNIFESP),
04023-062 Sa˜o Paulo, SP, Brazil
3 Instituto de Olhos Renato Ambro´sio, 20520-050 Rio de Janeiro, RJ, Brazil
Correspondence should be addressed to Patr´ıcia A. Bersanetti; bersanetti@unifesp.br
Received 2 June 2014; Revised 24 July 2014; Accepted 25 July 2014; Published 18 August 2014
Academic Editor: Suphi Taneri
Copyright © 2014 Amanda C. da Paz et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Corneal cross-linking (CXL) is increasingly performed in ophthalmology with high success rates for progressive keratoconus and
other types of ectasia. Despite being an established procedure, some molecular and clinical aspects still require additional studies.
This review presents a critical analysis of some established topics and others that are still controversial. In addition, this review
examines new technologies and techniques (transepithelial and ultrafast CXL), uses of corneal CXL including natural products
and biomolecules as CXL promoters, and evidence for in vitro and in vivo indirect effectiveness.
1. History
The concept of using collagen cross-linking photochemically
induced, for increasing corneal stiffness, as a conservative
method to stabilize ectasia progression was first conceived
in Germany in the 1990s by Theo Seiler and collaborators
[1–4]. Collagen cross-linking (CXL) opened a new horizon
for conscious biomechanical manipulation of the cornea
[5], which uses the concept of biomechanical customiza-
tion of therapeutic and refractive corneal surgery [6]. The
original “Dresden cross-linking clinical protocol” involves
topical anesthesia, central corneal abrasion, and application
of riboflavin 0.1% with 20% dextran T-500 until stromal sat-
uration is observed through biomicroscopy. The traditional
procedure is followed by ultraviolet A (UVA) light of 365–
370 nm at an irradiance of 3mW/cm2, which corresponds to
a dose of 5.4 J/cm2 for 30min [3].
The photopolymerization effect on corneal collagen
results from the reaction of the photosensitizer agent
riboflavin and UVA light (370 nm), which is the absorptive
peak of riboflavin. This reaction generates reactive oxygen
species that can react with various molecules and subse-
quently induce chemical covalent bonds that bridge the
amino groups of collagen fibrils [7]. Hayes et al. (2013)
demonstrated riboflavin/UVA-induced cross-links at the sur-
face of the collagen fibrils and within the proteoglycan (PG)
rich coating surrounding them [8]. In another study, Zhang
et al. (2011) reported that riboflavin/UVA treatment causes
beyond CXL among collagen molecules and among PG core
proteins, as well as limited linkages between collagen and PG
such as mimecan, decorin, keratocan, and lumican [9].
2. Other Approaches
2.1. Natural Cross-Linking. Human collagen undergoes pro-
gressive changes including a decrease in solubility, elasticity,
and permeability, as well as an increase in thermal stability
and resistance to enzymatic digestion with aging.The precise
chemical changes of these transformations are unknown.
However, an in vitro study has suggested that these physical
changes involve progressive CXL among collagen molecules
Hindawi Publishing Corporation
Journal of Ophthalmology
Volume 2014, Article ID 890823, 9 pages
http://dx.doi.org/10.1155/2014/890823
2 Journal of Ophthalmology
[10]. A detailed study of the collagen fibrils in normal human
corneas showed a small but significant age-related increase
in collagen fibrils for diameter, intermolecular spacing, and
elongation [11]. Expansion of the collagen intermolecular
spacing suggests molecules other than collagen are deposited
between the fibrils during aging, which subsequently push
the collagen molecules further apart.This is consistent with a
recent study that demonstrated glycation-induced expansion
of intermolecular spacing and subsequent CXL of molecules
with age [10]. Considering the isolated ultrastructural dimen-
sions of collagen fibrils, one would expect a tendency toward
biomechanical strengthening of the cornea during aging [12].
Hyperglycemia was shown to influence corneal biome-
chanical properties by inducing stromal collagen CXL
through glycosylation and lysyl oxidase (LOX) enzymatic
activity [13]. People with diabetes mellitus have increased
central corneal thickness, corneal hysteresis, and a corneal
resistance factor, possibly reflecting a greater stiffness of
diabetic corneas [14].
2.2. Biomolecules and Natural Products. Several studies have
demonstrated several molecules that might promote collagen
cross-link. Natural products such as genipin [15, 16] and
proanthocyanidins (PAs) [17] can form cross-links between
collagen fibrils. Avila et al. (2012) demonstrated in an ex vivo
study that corneal CXL with genipin was similar to the UV
traditional procedure, with minimal toxicity to endothelial
cells [16]. PAs are natural products with polyphenolic struc-
tures that have the potential to give rise to stable hydrogen
bonded structures and generate nonbiodegradable collagen
matrices. Han et al. (2003) demonstrated the feasibility
of using PAs from grape seeds to cross-link collagenous
materials [17].
Biomolecules, such as the leucine-rich proteoglycans
(e.g., decorin, lumican, and keratocan), regulate the orderly
assembly of extracellular matrices, corneal transparency,
tensile strength of skin and tendons, viscoelasticity of blood
vessels, and tumor cell proliferation. Experiments in vitro
showed that SLRPs interact with collagen through specific
binding sites and delay formation of collagen fibrils. To
modulate cornea collagen fibrillogenesis decorin binds to
collagen types I, II, III, VI, and XIV [18, 19].
3. In Vitro Effectiveness Evidences
3.1. Increase in Collagen Fiber Diameter. Riboflavin/UVA-
induced collagen CXL increases the corneal collagen fiber
diameter, which was more pronounced in the anterior por-
tion of the stroma of the rabbit cornea as observed on
transmission electron microscopy [23].
3.2. Resistance to Enzymatic Digestion. The stabilizing bio-
chemical effect of CXL can be explained by changes in the
tertiary structure of collagen fibrils induced by CXL prevent-
ing access of the proteolytic enzymes to their specific cleavage
sites by steric hindrance. In porcine corneas cross-linkedwith
riboflavin/UVA, CXL causes an impressive doubling in the
time following pepsin, trypsin, and collagenase digestion,
particularly in the anterior half of the cornea [22].
3.3.Modulus of Elasticity (Young’sModulus). Many published
studies report an increase in cornea stiffness after collagen
CXL. Wollensak et al. (2003) found a significant increase in
biomechanical rigidity by a factor of 4.5 in human corneas
following riboflavin/UVA-induced collagen CXL, which was
indicated by an increase in Young’s modulus. The increase in
biomechanical stiffness in porcine eyes was also significant by
a factor of 1.8 [20]. In another study, Wollensak and Iomdina
(2009) found a highly significant increase in corneal stiffness
after CXL treatment of rabbit corneas with an impressive
durability over time, as demonstrated by a 78.4%–87.4% (by a
factor of 1.6) increase in Young’s modulus by and a 69.7%–
106.0% increase in ultimate stress over the entire 8-month
follow-up [21]. Some limitations of this method are that the
strip specimens originated from a curved sample, the corneal
structure is disrupted because the lamellae are cut, and several
crucial constraints are ignored (e.g., real pachymetry and
meridional differences) [31].
3.4. Atomic Force Microscopy. Atomic force microscopy
(AFM) has a shaping probe tip that can scan the sample
surface at an atomic distance. By monitoring the interaction
force between the tip and the sample surface, this instrument
can create topographical images of the sample surface at
high resolutions [32]. When the probes approach the sample
surface, tiny interaction forces, such as Van der Waals and
electrostatic forces, occur between the probe and sample.
The resulting cantilever is recorded by measuring the dis-
placement of a laser beam reflected from the backside of
the cantilever. AFM can be applied to identify the collagen
bundles and to determine their diameters [33].This technique
provides quantitative information on the surfacemorphology
of the collagen fibrils at a high resolution [32]. Yamamoto
et al. (2002) clearly obtained surface topographic images of
human corneal and scleral collagen fibrils using AFM [32].
Further AFM studies are important to examine cross-link
induced modification in corneal collagen fibrils. Seifert et
al. (2014) developed a method that allows for atomic force
microscopy-based measurements of gradients of Young’s
modulus in soft tissues. In the abovementioned study, the
authors demonstrated the depth-dependent distribution of
the stiffening effect caused by riboflavin/UV CXL in porcine
corneas [34].
3.5. X-Ray Scattering. X-ray scattering is a specialized tech-
nique that provides structural information about the con-
stituent collagen in the corneal stroma. The wide-angle
equatorial scattering pattern produced from the lateral pack-
ing of molecules within the stromal collagen fibrils can be
used to determine the intermolecular spacing within the
fibrils, as well as the arrangement and distribution of fibrillar
collagen in the intact cornea [35, 36]. X-ray scattering is
a unique method for measuring the lateral space between
individual fibril-forming collagen molecules at less than a
1mm resolution. This space is influenced by both the fibril
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hydration and the extent of molecular CXL [35]. Studies of
corneal collagen organization in keratoconus (KC) suggest
that the mechanism of tissue thinning in this disease involves
fibrillar or lamellar collagen slippage, decreased lamellar
interweaving [35, 37], and distortion of the orthogonalmatrix
[37]. The authors of study proposed that development of
interventional cross-linking strategies may limit collagen
slippage and should be beneficial for delaying the progression
of keratoconus [35, 37]. In another study that analyzed CXL
in human corneas using X-ray scattering, Hayes et al. (2011)
concluded that UVA/riboflavin induced cross-links do not
have a measurable effect on the axial stagger or the tilt of
collagen molecules within the fibrils when analyzed using X-
ray scattering method [36].
3.6. Second Harmonic Generation Microscopy. Second har-
monic generation (SHG) microscopy has been used exten-
sively in medicine and biology to obtain images of highly
ordered structures, such as collagen fibers, microtubulin,
and skeletal muscle, with high resolution and contrast. This
nonlinear opticalmicroscopy results from a coherent second-
order nonlinear scattering wherein a noncentrosymmetric
structure emits light at half the wavelength of the incident
(pump) optical field. Collagen fibers, being intrinsically non-
centrosymmetric, emit SHG and thus produce high-contrast
images without the need for staining [38].
Collagen fibrils are aligned uniformly in the corneal
stroma and are therefore believed to be responsible for SHG
from the cornea. SHG imaging has thus allowed visualization
of collagen organization and can be processed to generate
three-dimensional reconstructions of collagen structure [39].
In 12 of 13 human keratoconic corneal samples obtained
after penetrating keratoplasty for KC, SHG could detect dif-
ferences in the organizational pattern of lamellae, including
a marked loss or decrease in anterior lamellae interweaving
and lamellae that inserted into Bowman’s layers [40].
Analysis of porcine corneas with and without
riboflavin/UVA CXL treatment using SHG showed that
stromal collagen fibrils in untreated corneas had a more
regular, linear, and parallel orientation. However, treated
corneas had wavy stromal collagen fibrils [41].
4. In Vivo Indirect Effective Evidences
4.1. Visual Acuity. The primary goal of CXL is to improve
the biomechanical rigidity of corneal collagen to stop ectasia
progression [1, 2]. In the first published clinical trial, Wol-
lensak et al. (2003) reported stability after CXL treatment of
the eyes of 19 patients with progressive KC and with a mean
follow-up of 20 months (from 3 to 33 months) [3]. In this
series, visual acuity (VA) slightly improved in 15 eyes (65%).
The improved uncorrected visual acuity (UCVA) recorded
during the follow-up is partially explained by the sphere and
spherical equivalent reduction. However, these data also may
be related to a progressive reduction of the mean K power.
Furthermore, the increased best spectacle-corrected visual
acuity (BSCVA)may be linked to a reduction in the difference
between superior and inferior corneal hemimeridians (flat-
test versus steeper), expressed by the improvement in corneal
symmetry indexes. Moreover, an increased BSCVA may be
sustained by the statistically significant early reduction in
coma aberration [42].
4.2. Keratometry. In the first published clinical trial [3], there
was a variable disease regression observed in 16 cases (70%)
by a reduction of the maximal keratometry readings and
refractive error [3]. Similar results were observed in other
studies examining CXL for KC [43–50] and keratectasia
[48, 51–54]. Corneal reshaping [55] appears to be a more
reliable expression of CXL induced clinical and topographic
changes. Mean clinical and topographic improvements were
recorded from the end of the third postoperative month and
continued thereafter, reaching reliable stability in 24 months
[46]. In addition, Koller et al. (2009) found KMax to be an
important prognostic variable, which was associated with a
significant reduction in complications when excluding cases
with a KMax higher than 58D [56]. A higher chance of ectasia
regression, observed by flattening, was more likely if KMax
was higher than 54D [57].
4.3. Biomicroscopy. A stromal demarcation line, biomicro-
scopically detectable as early as 2 weeks after CXL treatment,
was described by Seiler and Hafezi (2006) as the first clinical
evidence of a physical effect of CXL on corneal tissue
[58]. The demarcation line does not refer to biomechanical
properties but represents the transition between cross-linked
anterior corneal stroma, with modified refractive and reflec-
tion properties, and the untreated posterior corneal stroma
[58]. Caporossi et al. (2010) found stromal edema, clinically
detectable by slit-lamp examination in 70% of patients,
occurred in the first 30 postoperative days. Temporary haze
occurred in 9.8% of cases, 14 cases in the first 3 months, and
2 cases after 6 months but disappeared progressively after
topical preservative-free steroid therapy [46].
4.4. Scheimpflug Photography and Optical Coherence Tomog-
raphy. The stromal demarcation line is also observed via
Scheimpflug photography [59–62] and optical coherence
tomography (OCT) [46, 63]. Visante OCT scans show a
higher reflectivity (hyperdensity) of this line, and after 6
months, stromal reflectivity becomes more homogeneous,
reducing the visibility of the line in some eyes much more
than in others [46].
4.5. Pachymetry. Thepachymetric map provides the thinnest
point data, which is critical for ensuring the safety parameters
for the endothelium [64]. The thickness map also should be
important formonitoring results after CXL. Corneal thinning
has been documented in the early CXL postoperative course,
with a gradual return on corneal thickness toward preopera-
tive values within the first year after CXL [45, 46, 62, 65].
4.6. Ocular Response Analyzer. Until the launching of the
ocular response analyzer (ORA) (Reichert Inc., Depew, NY)
in 2005 [66], corneal biomechanical studies were limited to
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laboratory in vitro studies and virtual mathematical corneal
finite elementmodels [67, 68]. ORA is amodified noncontact
tonometer (NCT) that was designed to provide a more
accurate measurement of IOP through an understanding of
compensation for corneal properties [66].
During an ORA measurement, a precisely metered air
pulse is delivered to the eye, causing the cornea to move
inward, past a first applanation (flattening), and into a slight
concavity. Milliseconds after the first applanation, the air
pump generating the air pulse is shut down and the pressure
applied to the eye decreases in an inverse-time symmetrical
fashion. As the pressure decreases, the cornea passes through
a second applanated state while returning from concavity to
its normal convex curvature [66].
An electrooptical collimation detector system moni-
tors the corneal curvature in the central 3.0mm diame-
ter throughout the 20-millisecond measurement. A filtered
(smoothed) version of the detector signal defines 2 precise
applanation times corresponding to 2 well-defined peaks
produced by inward and outward applanation events. Two
corresponding pressures of an internal air supply plenum
are determined from the applanation times derived from the
detector applanation peaks [66].
The system registers the independent applanation pres-
sures during the ingoing (P1) and outgoing (P2) phases.
The difference between the 2 pressures is called corneal
hysteresis (CH) [69, 70]. Corneal resistance factor (CRF) is
also calculated from P1 and P2 with an optimized function
designed to augment the correlation with thickness in a
normal population [66, 70]. CH and CRF were significantly
lower in keratoconus, but CH and CRF were unchanged
after CXL [71–73]. Hysteresis is a viscoelastic property of
the cornea that is not directly related to stiffness [74]. A
new set of parameters derived from the waveform ORA
signal that monitors the deformation response of the cornea
during an ORA measurement has been reported [72–76].
These parameters had a better diagnostic performance for
keratoconus [75, 76]and improved after CXL [74, 76].
4.7. Corvis. Corvis has an ergonomic design. The patient is
comfortably positioned with proper placement of the chin
and forehead and then asked to focus on a central red LED.
A frontal view camera is mounted with a keratometer-type
projection system for focusing and aligning the corneal apex.
The examination is programmed for automatic release when
alignment is achieved with the first Purkinje reflex of the
cornea [77].
This equipment is a NCT system integrated with an
ultrahigh speed (UHS) Scheimpflug camera that was intro-
duced by Ambro´sio Jr et al. (2013) [77]. The CorVis ST
(Scheimpflug Technology) records 4,330 frames per second,
with a Scheimpflug camera that covers 8mm horizontally, to
monitor the corneal response to a fixed profile air pulse with
a maximal internal pump pressure of 25 kPa. The addition of
an UHS Scheimpflug camera allows dynamic inspection of
the actual deformation process that provides further details
for biomechanical characterization of the cornea.
The recording starts with the cornea at the natural convex
shape. The air puff forces the cornea inward (ingoing phase)
through applanation (first or ingoing applanation) into a
concavity phase until it achieves the highest concavity (HC).
Thereafter, the cornea undergoes a second applanation before
achieving its natural shape [77].The parameters derived from
the corneal response such as corneal speed during defor-
mation, corneal applanation length, deformation amplitude
(greatest displacement of the apex at the point of HC), and
radius of curvature at HC are important measures of corneal
viscoelastic properties and stiffness. Such parameters are
useful for the diagnosis of ectasia [75] and assessing CXL
results.
In an ancillary study conducted at the Ohio State
University in an industry-sponsored FDA trial of corneal
collagen CXL, subjects were evaluated biomechanically using
the CorVis ST before and after the procedure. Preliminary
analysis at 1-month postprocedurewas performedwith 11 ker-
atoconic subjects randomly selected for treatment, compared
with 8 keratoconic subjects randomly selected for the sham
group. A significant difference (𝑃 < 0.0014) was found in the
radius of curvature at HC in subjects who received treatment,
which is consistent with increased stiffness. Subjects in the
sham group showed no difference (𝑃 = 0.6981) at 1 month
[77].
4.8. Confocal Microscopy. In vivo confocal analysis showed
disappearance of keratocytes in the anterior midstroma to
a depth of 340 𝜇m [55] and a clear vertical transition area
between the edematous hyporeflective stroma with apoptotic
bodies and normoreflective deep stroma. After 6 months, the
reflectivity of the anterior midstroma was inverted (hyper)
compared with initial postoperative reflective previously
demonstrated [55]. Changes in the stromal reflectivity after
the sixth month are an important indirect (confocal) sign of
corneal CXL [55]. In general, after the third month, there is
new collagen synthesismeditated by repopulating keratocytes
and lamellar compaction, expressed by the hyperreflective-
ness of the extracellularmatrix, combinedwith newly formed
collagen fibers identified with in vivo confocal scans [55,
78]. In addition to this finding, nerve plexus degeneration
was noted up to 6 months postoperatively following CXL
[79].
Confocal microscopy demonstrated numerous hyper-
reflective spherical structures more abundantly in the ante-
rior stroma, and they were visible up to a depth of 300𝜇m
after CXL [80]. It is not clear what these structures repre-
sent; however, they may represent damaged keratocytes or
nuclear and cellular fragments. The stroma had a spiculated
appearance and extended to a depth at 300𝜇m that could be
secondary to changes in stromal hydration [80].
The increase of collagen fiber diameter could partly
explain the increased scattering of the collagen fibers creating
a net-like formation observed at the first and third months
after CXL [81]. In addition, revelation of the otherwise
unseen collagen fibers in the confocalmicroscopy images also
suggest alterations of the normal collagen fiber formation that
is responsible for the transparency of the cornea in normal
conditions. This may also have implications on the vision
function and contrast sensitivity [81].
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Table 1: In vitro and in vivo evidences of corneal cross-linking protocols.
Protocol In vitro In vivo
Epi-off CXL (Dresden Protocol)
Increased Young’s modulus [20, 21], resistance to
enzymatic degradation [22], and collagen fiber
diameter [23]
Improvement in VA, K reading, refraction, and
halt of ectasia progression
Epi-on CXL
Riboflavin penetration requires more time than with
epi-off techniques
Epithelium permeabilization can be achieved with
molecules as cyclodextrins [24] and benzalkonium
chloride in association with NaCl [25]
Improvement in VA and topographic findings
Halt of ectasia progression
There is a lot of controversy about results of
this technique [26]
Ultrafast CXL Young’s modulus similar to traditional CXL [27] Equivalent in VA, refraction and pentacamparameters [28, 29], and OCT imaging [29]
Athens protocol No data available
Superiorly with a better BSCVA, mean K
reduction, spherical equivalent, and corneal
haza score [30]
5. Another Crosslinking Protocols
5.1. Transepithelial Cross-Linking (Epithelial Damage versus
Amphiphilic Molecules). Analysis of the light transmission
spectra of porcine corneas following riboflavin/UVA corneal
CXL treatment suggests a need for completely removing the
epithelium to allow adequate and homogeneous penetration
of riboflavin into the stroma [82]. A grid pattern of full
thickness epithelial debridement appears to allow some
riboflavin stromal penetration; however, this was less sig-
nificant compared with that observed after complete central
epithelium removal [82]. An application of 20% alcohol in
the presence of an intact epithelium is not sufficient to
allow adequate riboflavin penetration into the corneal stroma
[82]. A riboflavin complex with ethylenediaminetetraacetic
acid (EDTA) and trometamol was used for transepithelial
CXL after superficial scraping. However, the uptake was
considerably less than in corneas with epithelium removed
[83]. Pharmacological permeabilization of epithelium was
achieved by applying cyclodextrins that enhance riboflavin
solubility in water and to improve its permeability through
bovine corneas [24]. Raiskup et al. (2012) showed that a
riboflavin solution without dextran, but including 0.01%
benzalkonium chloride and 0.44% NaCl promoted the per-
meability through the epithelium, resulting in a sufficient
concentration of riboflavin in the stroma [25]. Recently,
Bottos et al. (2013) described riboflavin nanoemulsions that
could penetrate the corneal epithelium. A greater stromal
concentration was detected after 240min when compared
with corneas submitted to the standard protocol [84]. Bik-
bova and Bikbov (2014) showed the effectiveness of the
impregnation of riboflavin 0.1% in eyes of 19 patients by
iontophoresis in transepithelial collagen CXL with a decrease
in the average keratometry 1 year after the procedure [85].
5.2. Athens Protocol. Kanellopoulus et al. (2009) studied
topography-guided PRK at least 6 months following CXL
and topography PRK followed immediately by CXL in a
single procedure in adults with advancing KC to stabilize
ectasia and rehabilitate vision (with topography-guided PRK)
[30]. The simultaneous procedure appeared to be superior to
sequential treatments in rehabilitation of keratoconus with
minimal haze formation, and in addition to a reduction in the
patient’s time away fromwork. Perhaps CXLwill have a wider
application as prophylaxis in laser refractive surgery [30]. In
another study, the same author found potentially promising
results with the same-day and simultaneous topography-
guided PRK and collagen CXL as a therapeutic intervention
in highly irregular corneas with progressive corneal ectasia
after LASIK [86].
5.3. Ultrafast Cross-Linking. According to the Bunsen and
Roscoe (1862) law, the effect of a photochemical or pho-
tobiological reaction is directly proportional to the total
irradiation dose, irrespective of the time span over which
the dose is administered [87]. Schumacher et al. (2011) found
an increase in Young’s modulus statistically equivalent in the
group of porcine corneas treated with illumination intensity
of 10mW/cm2 and 3 times shorter illumination time of 9min
compared with a group with an intensity of 3mW/cm2 that
required an illumination time of 30min [27]. High fluence
and UV light used with shorter exposure appears to be safe
and effective in stabilizing keratoconus, and this technique
appears to be similar but more comfortable for patients [28].
In Table 1 are showed in vitro and in vivo evidences of
Dresden protocol and the new approaches of CXL.
6. Conclusions
Clinical assessment of biomechanical properties represents
an area of active research. Novel nondestructive methodolo-
gies have been described, including radial shearing speckle
pattern interferometry [88, 89], Brillouin optical microscopy
[90], and other forms of dynamic corneal imaging [91, 92].
These approaches may soon be developed into commercially
available instruments.
CXL has revolutionized the treatment of ectatic diseases.
However, considering the goal of the procedure is to stiffen
corneal tissue, thereby stabilizing ectasia progression, charac-
terization of the cornea should go beyond shape analysis into
biomechanical assessment. Such characterization is critical
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for enabling conscious optimization and further improve-
ments in CXL techniques. Such advances should significantly
affect the indication, planning, and postoperative evaluation
of ectasia treatments.
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